Incannex appoints Dr. Kirsch to OSA board; Phase 2 data due July 2025

Incannex Healthcare Inc.

Appointed Douglas B. Kirsch, M.D., FAAN, FAASM to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
Dr. Kirsch is Medical Director of Atrium Health Sleep Medicine and former President of the American Academy of Sleep Medicine.
Company expects to report topline Phase 2 data from the U.S. RePOSA study in July 2025.
Phase 3 initiation for IHL-42X targeted for later in 2025.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.